SECTIONS

China stocks rise; vaccine scandal caps gains

* Shanghai stocks higher, blue-chip CSI300 index up

* Guizhou Changzheng Tiancheng Holding leads

* China's A-shares at 20.64 pct premium over H-shares

SHANGHAI, July 23 (Reuters) - China stocks rose on Monday,
aided by strength in financials and industrial stocks, but a
slump in healthcare shares amid a vaccine scandal capped broader
gains.
** The blue-chip CSI300 index rose 0.9 percent to
3,525.75 points while the Shanghai Composite Index ended
up 1.1 percent at 2,859.54 points.
** An index tracking major healthcare firms on the
mainland slumped 4.1 percent, led by a 10 percent drop in
Chongqing Zhifei Biological Products, hit by a
selloff after a major vaccine maker last week was found to have
violated standards in making rabies vaccine for humans.
** Chinese Premier Li Keqiang has called for an immediate
investigation into the scandal over faulty vaccines that he said
had crossed a moral line, and urged severe punishment for the
companies and people implicated.
** Meanwhile, investors bought financial and industry stocks,
after China released draft rules and guidelines to strengthen
regulations of financial institutions' wealth management and
asset management businesses.
** Earlier on Friday, the China Banking and Insurance Regulatory
Commission (CBIRC) released long-awaited draft rules on
commercial banks' wealth management products (WMPs), saying that
these WMPs should be managed based on their net value.
** "The biggest concern among market participants for Beijing's
deleveraging campaign is a one-size-fits-all approach which
could cut off liquidity," said Yang Hai, strategist at Kaiyuan
Securities.
** The new draft rules eased the concern and will bode well for
banking firms, Yang added.
** Around the region, MSCI's Asia ex-Japan stock index
was weaker by 0.11 percent while Japan's Nikkei
index closed down 1.33 percent.


** At 07:07 GMT, the yuan was quoted at 6.775 per
U.S. dollar, 0.17 percent firmer than the previous close of
6.7864.
** The largest percentage gainers in the main Shanghai Composite
index were Guizhou Changzheng Tiancheng Holding Co Ltd
, up 10.13 percent, followed by Long Yuan
Construction Group Co Ltd, up 10.06 percent and Bank
of Chengdu Co Ltd, up 10.05 percent.
** The largest percentage losers in the Shanghai index were
Shanghai Hile Bio-Technology Co Ltd and Henan
Oriental Silver Star Investment Co Ltd, down 10.01
percent each, followed by Nanjing King-friend Biochemical
Pharmaceutical Co Ltd, down by 9.99 percent.
** So far this year, the Shanghai stock index is down 13.5
percent, the CSI300 has fallen 12.5 percent while China's
H-share index listed in Hong Kong is down 8.1 percent. Shanghai
stocks have risen 0.42 percent this month.
** About 17.34 billion shares were traded on the Shanghai
exchange, roughly 133.2 percent of the market's 30-day moving
average of 13.02 billion shares a day. The volume in the
previous trading session was 14.59 billion.
** As of 07:08 GMT, China's A-shares were trading at a premium
of 20.64 percent over the Hong Kong-listed H-shares.
** The Shanghai stock index is below its 50-day moving average
and below its 200-day moving average.
(Reporting by Shanghai Newsroom; Editing by Vyas Mohan)


2018-07-23 09:27:52

© 2018 Thomson Reuters. All rights reserved. Reuters content is the intellectual property of Thomson Reuters or its third party content providers. Any copying, republication or redistribution of Reuters content, including by framing or similar means, is expressly prohibited without the prior written consent of Thomson Reuters. Thomson Reuters shall not be liable for any errors or delays in content, or for any actions taken in reliance thereon. "Reuters" and the Reuters Logo are trademarks of Thomson Reuters and its affiliated companies.